BIK

Across TCGA pan-cancer cohorts, BIK mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of BIK’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where BIK mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types BIK is over-expressed in tumor, although a few such as HNSC and CCRCC show the opposite, repressed pattern.

HNSC and CCRCC are the cancer types where BIK tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BIK mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	−0.418	.002	8	view →
CCRCC	All	All	−0.284	.001	8	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

BIK–HNSC

Open the HNSC breakdown →